tirzepatide review Semaglutide vs Tirzepatide: Key Differences tirzepatide review article for diabetes:

Through co-immunoprecipitation (CO-IP) experiments, we discovered that FOXO4-DRI prevents the binding of FOXO4 to P53, facilitating the phosphorylated P53 nuclear exclusion, which subsequently trigger BAX and cleaved caspase-3, leading to the apoptosis of senescent cells

The article says these carry no breastfeeding safety concerns and support postpartum metabolic health alongside milk supply

CrAT deficiency suppressed the residual glucose dependent de novo lipogenesis in ACLY KO cells and abrogated the effect of carnitine supplementation in promoting de novo lipogenesis (Figure 6G, Supplemental Figure 7I)

8.2 Lactation Risk Summary A clinical lactation study reported semaglutide concentrations below the lower limit of quantification in human breast milk